In a longer and larger observational study of German patients, followed up for 1–31 years, mortality was 43% among the seven untreated homozygotes compared with 21% in the 14 who were treated with Lp ...

Drs Brinton and Michos highlight LDL-C apheresis in the treatment landscape for homozygous familial hypercholesterolemia [HoFH]. Eliot Brinton, MD: What do we do if the standard treatments don’t work?

Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, ...

B. Braun Medical’s renal therapies division has announced the availability of the Plasmat Futura System for heparin-induced extracorporeal lipoprotein precipitation (HELP) LDL Apheresis therapy. HELP ...

An acute reduction in total cholesterol of ≥65%, or in LDL cholesterol of ≥70%, during each procedure; An interval mean total cholesterol of <7 mmol/l or LDL cholesterol <6.5 mmol/l (or decreases of ...